Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Joincare's LZSN2501 Cleared for Phase I Clinical Trials by NMPA – Dual-Epitope Bispecific Anti-FXI Antibody Targets VTE Prevention After Total Knee Arthroplasty
CompanyDrug

Joincare’s LZSN2501 Cleared for Phase I Clinical Trials by NMPA – Dual-Epitope Bispecific Anti-FXI Antibody Targets VTE Prevention After Total Knee Arthroplasty

Joincare Pharmaceutical Group Industry Co., Ltd. (SHA: 600380) announced that its recombinant humanized anti-FXI bispecific antibody injection, LZSN2501, has been approved by China's National Medical Products Administration (NMPA) to conduct…

Hengrui's Remimazolam Tosylate Wins China Approval for ICU Sedation During Mechanical Ventilation – Ruibeining Expands Into Critical Care

Hengrui’s Remimazolam Tosylate Wins China Approval for ICU Sedation During Mechanical Ventilation – Ruibeining Expands Into Critical Care

Enhertu Wins EU Approval in Resected HER2-Positive Breast Cancer – Daiichi Sankyo's ADC Cuts Recurrence Risk by 53% Versus T-DM1

Enhertu Wins EU Approval in Resected HER2-Positive Breast Cancer – Daiichi Sankyo’s ADC Cuts Recurrence Risk by 53% Versus T-DM1

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Huadong Medicine Gets FDA Nod for Phase I Study of HDM2006 in Solid Tumors
CompanyDrug

Huadong Medicine Gets FDA Nod for Phase I Study of HDM2006 in Solid Tumors

Tonghua Dongbao Begins Phase II Trial for GLP-1/GIP Agonist THDBH120 in Weight Loss
CompanyDrug

Tonghua Dongbao Begins Phase II Trial for GLP-1/GIP Agonist THDBH120 in Weight Loss

CSPC Pharmaceutical's ADC Pipeline Advances with SYS 6041 Approval
CompanyDrug

CSPC Pharmaceutical’s ADC Pipeline Advances with SYS 6041 Approval

Henlius Biotech Gains NMPA Clearance for HLX43 ADC Study
CompanyDrug

Henlius Biotech Gains NMPA Clearance for HLX43 ADC Study

Ucello Biotech's UC101 Receives FDA IND Clearance for Anti-CD19 Therapy
CompanyDrug

Ucello Biotech’s UC101 Receives FDA IND Clearance for Anti-CD19 Therapy

Hengrui Pharmaceuticals Gets NMPA Approval for SHR-1819 Phase II Study
CompanyDrug

Hengrui Pharmaceuticals Gets NMPA Approval for SHR-1819 Phase II Study

Hengrui Pharmaceuticals Receives NMPA Approval for SHR-4375 Clinical Trial
CompanyDrug

Hengrui Pharmaceuticals Receives NMPA Approval for SHR-4375 Clinical Trial

Doma Biopharma Receives FDA Clearance for DM002 Phase I Study
CompanyDrug

Doma Biopharma Receives FDA Clearance for DM002 Phase I Study-Fineline Info & Tech

Show More